Oric Pharmaceuticals Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1,578.0% | – | – | – | -2,631.7% | – | – | – | – | – | – | – | |
| – | 17.1% | – | – | – | 28.5% | – | – | – | – | – | – | – | |
| – | 255.1% | – | – | – | 488.1% | – | – | – | – | – | – | – | |
| – | 129.0% | – | – | – | 410.9% | – | – | – | – | – | – | – | |
| – | 3.7% | – | – | – | 20.5% | – | – | – | – | – | – | – | |
| – | 1,363.0% | – | – | – | 4,001.4% | – | – | – | – | – | – | – | |
| – | -1,119,662.5% | – | – | – | – | – | – | – | – | – | – | – | |
| – | 29.5% | – | – | – | 53.9% | – | – | – | – | – | – | – | |
| – | -185.6% | – | – | – | 1,423.6% | – | – | – | – | – | – | – | |
| – | -1,581.7% | – | – | – | -2,652.3% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.